Covid-19 vaccine

The petitioner, Yogendra Kumar, has approached the Gujarat High Court for quashing the show cause notice dated 10.05.21 issued by Indian Air Force seeking explanation as to why the Petitioner service should not be terminated for his refusal to take the Covid-19 vaccine.

The notification by Supreme Court states that candidates must take both doses of the COVID19 vaccine & inform the same latest by November 17.

The bench of Chief Justice D.N. Patel and Justice Jyoti Singh said it shall keep the petition pending, but added that it cannot expedite the same as if something is missed or goes wrong it will be a disaster.

The company has given conditions to the centre for supply of its vaccine, including not undertaking bridging trials and waiver of indemnity. But experts warn against removing all regulatory oversight.

The division bench of Chief Justice Sanjib Banerjee and Justice Senthilkumar Ramamoorthy passed this order while hearing a suo motu case registered to monitor COVID-19 management in Tamil Nadu and Puducherry.

A petition was filed in the Supreme Court, seeking cancellation of FIRs registered against those putting up posters opposing Prime Minister Narendra Modi regarding the Covid-19 vaccine.

In the second wave of COVID-19, the concerned Petitioner Association stated, “COVID-19 vaccine is a life-saving drug and the same shall be included in the National list of Essential Medicines.

The Central informed the Apex Court that the differential pricing of coronavirus vaccines is intended to create an incentivized demand for private producers, resulting in market-driven low prices.

The Supreme Court has stayed the hearing of the PIL related to the pending corona vaccine in the Delhi High Court.

The Delhi High Court on Wednesday told the Centre that the Judiciary is one of the three wings of Government and an important wing of the State. Solicitor General Tushar Mehta had submitted that only those who are 60-plus or with co-morbidities have been considered for the first phase of vaccination.